- Home
- FCNCA vs WAT Comparison
FCNCA vs WAT Comparison
Compare FCNCA & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCNCA | WAT |
|---|---|---|
| Founded | 1898 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.0B | 32.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | FCNCA | WAT |
|---|---|---|
| Price | $1,902.95 | $306.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 18 |
| Target Price | ★ $2,199.60 | $386.59 |
| AVG Volume (30 Days) | 102.5K | ★ 1.7M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | N/A | ★ 10.76 |
| Revenue | N/A | ★ $3,165,286,000.00 |
| Revenue This Year | $3.43 | $103.90 |
| Revenue Next Year | N/A | $11.12 |
| P/E Ratio | ★ $12.17 | $28.24 |
| Revenue Growth | N/A | ★ 6.99 |
| 52 Week Low | $1,473.62 | $275.05 |
| 52 Week High | $2,232.21 | $414.15 |
Technical Indicators
Market Signals| Indicator | FCNCA | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 32.96 |
| Support Level | $1,780.68 | $305.35 |
| Resistance Level | $2,196.46 | $308.14 |
| Average True Range (ATR) | 71.49 | 9.69 |
| MACD | -8.18 | 0.19 |
| Stochastic Oscillator | 31.76 | 27.03 |
Price Performance
Historical ComparisonAbout FCNCA First Citizens BancShares Inc.
First Citizens is a US regional bank with total assets of over $230 billion as of Sept. 30, 2025. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of making troubled bank acquisitions from the FDIC, like the 2023 acquisition of Silicon Valley Bridge Bank, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2024.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.